Citadel Advisors’s PolyPid PYPD Stock Holding History
Bought
Maintained
Sold
Other funds holding PYPD
ACM
RA
DCM
JGC
ACM
SPM
LK
XT
Citadel Advisors's PYPD Position: Q1 2026 in Review
Citadel Advisors increased its PolyPid (PYPD) stake by 439% in Q1 2026, buying an estimated $208K and bringing the position to 57,769 shares worth $253K. The position accounts for ﹤0.01% of the portfolio, ranked #10881.
Citadel Advisors first reported a position in PYPD in Q2 2020 and has held it in 11 quarters since. The position peaked at $1.65M in Q2 2020. 19 funds tracked by Wall St. Rank hold PYPD as of Q1 2026.
- Citadel Advisors held 57,769 shares of PolyPid worth $253K as of Q1 2026.
- Citadel Advisors bought 47,046 PolyPid shares in Q1 2026, an estimated $208K.
- PolyPid made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #10881 holding.
- Citadel Advisors first reported a position in PolyPid in Q2 2020 and has held it in 11 quarters since.
- Citadel Advisors's PolyPid position peaked at $1.65M in Q2 2020.
- 19 funds tracked by Wall St. Rank held PolyPid as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.